Myo-Inositol Trispyrophosphate (ITPP) + Cardarine (GW-501516) Stack

Myo-Inositol Trispyrophosphate (ITPP) Cardarine (GW-501516) Stack – Product Information

ITPP is a compound that has been investigated for its potential effects on enhancing oxygen utilization and improving endurance. It is believed to work by increasing the release of oxygen from red blood cells to tissues, potentially leading to improved physical performance. ITPP has shown promise in animal studies, but its effects and safety in humans are not well-established.

Cardarine, also known as GW-501516, is a compound that has been researched for its potential benefits on endurance and fat burning. It has been shown to activate a protein called PPAR-delta, which can influence various metabolic pathways, including those involved in energy expenditure and lipid metabolism.

Given that ITPP and Cardarine have different mechanisms of action, the idea behind combining them could be to potentially enhance endurance and aerobic capacity further in a research setting.

• This stack consists of ITTP Cardarine.
• Tablets: 70 mg per tablet (50 mg ITPP and 20 mg Cardarine)
  Available in 27 tablets (1890 mg) and 54 tablets (3780 mg).

ITTP

ITTP or Myo-inositol trispyrophosphate is a research compound currently being investigated in hopes of aiding patients weakened by myocardial infarctions due to its ability to increase oxygen supply to weakened or damaged cardiac muscle. Designed to make hemoglobin increase its release of oxygen above normal levels, ITPP has the potential ability to boost exercise levels in ailing mice by up to 35% when given dissolved in water. When administered via injection into the abdomen, exercise levels saw a potential rise of up to a massive 60%. Further research is warranted to investigate the potential of ITPP in oxygen transport and endurance training.

Cardarine (GW-501516)

GW-501516, also known as Cardarine, is a PPAR agonist. Cardarine is used in research for its potential to facilitate fat-burning by increasing endurance and stamina. A study done on the effects of GW-501516 for enhancing running endurance in Kunming mice demonstrated that a 3-week dosing protocol with GW-501516 was able to increase performance related to running of both trained and untrained mice. Similar to training, GW501516 showed an increase in mitochondrial fatty acid oxidation and enhanced fat metabolism in muscle tissue. This could potentially lead to less demanding cardiovascular work, increasing weekly deficits, and resulting in increased fat loss.